Serum-dependent processing of late apoptotic cells for enhanced efferocytosis. - Wikidata - awgldk - TriplyDB

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis.

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis.

http://www.wikidata.org/entity/Q40387482

about

Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources.Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.Clearance of Apoptotic Bodies, NETs, and Biofilm DNA: Implications for Autoimmunity Serum-dependent processing of late apoptotic cells and their immunogenicity.Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation.In vitro Antiproliferative and Apoptosis Inducing Effect of Allium atroviolaceum Bulb Extract on Breast, Cervical, and Liver Cancer Cells.The immune response to secondary necrotic cells.Impaired efferocytosis by monocytes in multiple myeloma.

P2860

Q28397407-0B998098-ACC1-4C6E-81C2-4CB0B1558C18 Q35951268-A187A673-93D0-40B7-B18D-3D91B6126BAF Q36578796-2DAEB3C8-A4CF-4E8B-8563-F648FF450885 Q38240144-0CC69A54-1EFF-480B-93AA-44DC27D4FB1E Q38837767-4C8B671E-6203-40A7-A751-942089000F90 Q39032748-07EA6303-38ED-4101-800E-294E98140D49 Q42325997-22C09B99-B292-4CF4-9421-2FA9B622D51F Q42371859-4AB63863-C5B6-4D0D-8A21-A3FA299A0BFA Q55310900-F30F2444-796A-4356-95E8-017AE69495B5

P2860

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis.

http://www.wikidata.org/entity/Q40387482

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis.

@en

type

label

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis.

@en

prefLabel

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis.

@en

P1433

Q40387482-0343D0DB-6BC8-409E-8EE7-652AE223A321

P1476

Q40387482-38DDE72C-A67D-44FB-BA4B-667678641239

P2093

Q40387482-141E0516-4AB1-493E-AB24-9804AC864CC7

Q40387482-4910D7F5-AFAC-4C55-8A4F-BB97F6666EC0

Q40387482-77AF8D8E-65E9-457A-9884-E0E26C4BC5D1

Q40387482-86A71A40-01A8-4E15-84C3-2DE7D81CE75D

Q40387482-B76365F7-8607-4C12-8899-3E93439CE801

P2860

Q40387482-0C679013-813D-4974-B6DB-BF0E8E2BCD97

Q40387482-12930915-8973-4693-8C2C-2C4391256736

Q40387482-282AD803-FD9C-45CA-93F6-2A96A75AB947

Q40387482-3C75799E-A233-4A73-A7C2-1AFD44C65968

Q40387482-3DF4CE31-4B02-4768-A994-49C789E697E5

Q40387482-43D920F4-78BB-4F51-BABC-A1E3217382CD

Q40387482-46FB5F73-DACC-4D32-A435-E3F4E42E8002

Q40387482-6B32009A-8AB9-44D0-9359-C8002554DFC2

Q40387482-6FCCA4BA-B371-4417-BF69-4E87354E63EC

Q40387482-8C179D58-A640-40EE-A1D2-5F01750E9517

P304

Q40387482-D76EDDD6-0535-454E-8A8E-1D091E50E661

P31

Q40387482-8ECA223E-0054-4724-9170-64C281B38F76

P356

Q40387482-F195780B-2799-4FFB-B53C-56CAFC5CCE6B

P478

Q40387482-6FB2021F-D169-4DD3-9271-BDEE256946D3

P50

Q40387482-E2E8BD29-E577-4FE7-9A72-68D988814EFE

Q40387482-F251390C-B7C8-4B12-B49B-4CB9DCB8B792

P577

Q40387482-7EB54298-55B1-4CFF-A4F7-B840C7C35CAB

P5875

Q40387482-55C64591-B608-470E-995A-D63971604C82

P698

Q40387482-0A7749C6-53A9-4386-B5FD-3182C5DEA297

P921

Q40387482-BF761F40-BE99-454A-B64C-11EF20C81241

P932

Q40387482-B95E0FBB-9FEE-42B9-95A7-DA542D105A08

P356

P1433

Cell Death and Disease

P1476

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis

@en

P2093

A Michlmayr

http://www.w3.org/2001/XMLSchema#string

B Perticevic

http://www.w3.org/2001/XMLSchema#string

D Rainprecht

http://www.w3.org/2001/XMLSchema#string

T Arnold

http://www.w3.org/2001/XMLSchema#string

Y Y Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells

Apoptotic cell clearance: basic biology and therapeutic potential.

Resolution of inflammation: an integrated view

C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition

Clearance of apoptotic cells: implications in health and disease

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.

A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion.

Molecular mechanisms of late apoptotic/necrotic cell clearance.

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.

Complement and apoptosis.

P304

e1264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2014.210

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Spittler

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262734367

http://www.w3.org/2001/XMLSchema#string

P698

24874736

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

4047901

http://www.w3.org/2001/XMLSchema#string